市場調査レポート
商品コード
1110489

ヒトの猫アレルギーの世界市場:業界分析、規模、シェア、成長、動向、予測(2022年~2031年)

Cat Allergy in Humans Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 191 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヒトの猫アレルギーの世界市場:業界分析、規模、シェア、成長、動向、予測(2022年~2031年)
出版日: 2022年06月02日
発行: Transparency Market Research
ページ情報: 英文 191 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のヒトの猫アレルギー市場について調査し、市場規模や予測、市場力学、セグメント・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界のヒトの猫アレルギー市場

第4章 市場概要

  • イントロダクション
    • 定義
    • 業界の進化/発展
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界のヒトの猫アレルギー市場の分析と予測(2017年~2031年)

第5章 主な洞察

  • 主な合併と買収
  • アレルギー有病率データ
  • パイプライン分析
  • COVID-19パンデミックの業界への影響(バリューチェーンと短期・中期・長期の影響)

第6章 世界のヒトの猫アレルギー市場分析と予測:治療別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場予測(金額):治療別(2017年~2031年)
    • コルチコステロイド鼻スプレー
    • うっ血除去剤
    • ロイコトリエン阻害剤
    • その他
  • 市場の魅力

第7章 世界のヒトの猫アレルギー市場分析と予測:用途別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場予測(金額):用途別(2017年~2031年)
    • アレルギー治療
    • アレルギー予防
  • 市場の魅力

第8章 世界のヒトの猫アレルギー市場分析と予測:流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場予測(金額):流通チャネル別(2017年~2031年)
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力

第9章 世界のヒトの猫アレルギー市場分析と予測:地域別

  • 主な調査結果
  • 市場予測(金額):地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力

第10章 北米のヒトの猫アレルギー市場分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場予測(金額):治療別(2017年~2031年)
  • 市場予測(金額):用途別(2017年~2031年)
  • 市場予測(金額):流通チャネル別(2017年~2031年)
  • 市場予測(金額):国別(2017年~2031年)
    • 米国
    • カナダ
  • 市場魅力分析

第11章 欧州のヒトの猫アレルギー市場分析と予測

第12章 アジア太平洋のヒトの猫アレルギー市場分析と予測

第13章 ラテンアメリカのヒトの猫アレルギー市場分析と予測

第14章 中東・アフリカのヒトの猫アレルギー市場分析と予測

第15章 競合情勢

  • 市場企業 - 競合マトリックス:階層および企業規模別
  • 市場シェア分析:企業別(2020年)
  • 企業プロファイル
    • Bayer AG
    • Covis Pharma BV
    • HollisterStier Allergy.
    • GlaxoSmithKline plc
    • Merck &Co. Inc.
    • Regeneron Pharmaceuticals, Inc.
    • Saiba Animal Health AG
    • Sanofi, Stallergenes Greer
図表

List of Tables

  • Table 01: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 02: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017-2031
  • Table 03: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 08: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017-2031
  • Table 09: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 11: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 12: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 13: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017-2031
  • Table 14: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Asia Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 18: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017-2031
  • Table 19: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 23: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017-2031
  • Table 24: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 25: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 26: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 28: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017-2031
  • Table 29: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Cat Allergy in Humans Market Value Share, by Treatment, 2020
  • Figure 03: Cat Allergy in Humans Market Value Share, by Application, 2020
  • Figure 04: Cat Allergy in Humans Market Value Share, by Distribution Channel, 2020
  • Figure 05: Global Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 06: Global Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 07: Global Cat Allergy in Humans Market Value (US$ Mn), by Antihistamines, 2017-2031
  • Figure 08: Global Cat Allergy in Humans Market Value (US$ Mn), by Corticosteroid Nasal Sprays, 2017-2031
  • Figure 09: Global Cat Allergy in Humans Market Value (US$ Mn), by Decongestants, 2017-2031
  • Figure 10: Global Cat Allergy in Humans Market Value (US$ Mn), by Leukotriene Inhibitors, 2017-2031
  • Figure 11: Global Cat Allergy in Humans Market Value (US$ Mn), by Others, 2017-2031
  • Figure 12: Global Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 13: Global Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 14: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Allergy Treatment, 2017-2031
  • Figure 15: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Allergy Prevention, 2017-2031
  • Figure 16: Global Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 17: Global Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 18: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 19: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 20: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 21: Global Cat Allergy in Humans Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 22: Global Cat Allergy in Humans Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 23: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: North America Cat Allergy in Humans Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 25: North America Cat Allergy in Humans Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 26: North America Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 27: North America Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 28: North America Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 29: North America Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 30: North America Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 31: North America Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 32: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 33: Europe Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 34: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 35: Europe Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 36: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 37: Europe Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 38: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 39: Europe Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 40: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 41: Asia Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Asia Pacific Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 43: Asia Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 44: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 45: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 46: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 47: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 48: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 49: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 50: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 51: Latin America Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
  • Figure 52: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
  • Figure 53: Latin America Cat Allergy in Humans Market Value Share Analysis, by Treatment , 2020 and 2031
  • Figure 54: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 55: Latin America Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 56: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 57: Latin America Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 58: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 59: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 60: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
  • Figure 61: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
  • Figure 62: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Treatment , 2020 and 2031
  • Figure 63: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 64: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 65: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 66: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
  • Figure 67: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021-2031
目次
Product Code: TMRGL84817

The report provides revenue of the global cat allergy in humans market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cat allergy in humans market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cat allergy in humans market.

The report delves into the competitive landscape of the global cat allergy in humans market. Key players operating in the global cat allergy in humans market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cat allergy in humans market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cat Allergy in Humans Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cat Allergy in Humans Market Analysis and Forecasts, 2017-2031

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Allergy Prevalence Data
  • 5.3. Pipeline Analysis
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Cat Allergy in Humans Market Analysis and Forecasts, By Treatment

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Treatment, 2017-2031
      • 6.3.1.1. Antihistamines
    • 6.3.2. Corticosteroid Nasal Sprays
    • 6.3.3. Decongestants
    • 6.3.4. Leukotriene Inhibitors
    • 6.3.5. Others
  • 6.4. Market Attractiveness By Treatment

7. Global Cat Allergy in Humans Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2017-2031
    • 7.3.1. Allergy Treatment
    • 7.3.2. Allergy Prevention
  • 7.4. Market Attractiveness By Application

8. Global Cat Allergy in Humans Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2017-2031
    • 8.3.1. Hospital pharmacies
    • 8.3.2. Retail pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Cat Allergy in Humans Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Cat Allergy in Humans Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Treatment, 2017-2031
    • 10.2.1. Antihistamines
    • 10.2.2. Corticosteroid Nasal Sprays
    • 10.2.3. Decongestants
    • 10.2.4. Leukotriene Inhibitors
    • 10.2.5. Others
  • 10.3. Market Value Forecast By Application, 2017-2031
    • 10.3.1. Allergy Treatment
    • 10.3.2. Allergy Prevention
  • 10.4. Market Value Forecast By Distribution Channel, 2017-2031
    • 10.4.1. Hospital pharmacies
    • 10.4.2. Retail pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Treatment
    • 10.6.2. By Application
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Cat Allergy in Humans Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Treatment, 2017-2031
    • 11.2.1. Antihistamines
    • 11.2.2. Corticosteroid Nasal Sprays
    • 11.2.3. Decongestants
    • 11.2.4. Leukotriene Inhibitors
    • 11.2.5. Others
  • 11.3. Market Value Forecast By Application, 2017-2031
    • 11.3.1. Allergy Treatment
    • 11.3.2. Allergy Prevention
  • 11.4. Market Value Forecast By Distribution Channel, 2017-2031
    • 11.4.1. Hospital pharmacies
    • 11.4.2. Retail pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By Country, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Treatment
    • 11.6.2. By Application
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country

12. Asia Pacific Cat Allergy in Humans Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Treatment, 2017-2031
    • 12.2.1. Antihistamines
    • 12.2.2. Corticosteroid Nasal Sprays
    • 12.2.3. Decongestants
    • 12.2.4. Leukotriene Inhibitors
    • 12.2.5. Others
  • 12.3. Market Value Forecast By Application, 2017-2031
    • 12.3.1. Allergy Treatment
    • 12.3.2. Allergy Prevention
  • 12.4. Market Value Forecast By Distribution Channel, 2017-2031
    • 12.4.1. Hospital pharmacies
    • 12.4.2. Retail pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By Country, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Treatment
    • 12.6.2. By Application
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country

13. Latin America Cat Allergy in Humans Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Treatment, 2017-2031
    • 13.2.1. Antihistamines
    • 13.2.2. Corticosteroid Nasal Sprays
    • 13.2.3. Decongestants
    • 13.2.4. Leukotriene Inhibitors
    • 13.2.5. Others
  • 13.3. Market Value Forecast By Application, 2017-2031
    • 13.3.1. Allergy Treatment
    • 13.3.2. Allergy Prevention
  • 13.4. Market Value Forecast By Distribution Channel, 2017-2031
    • 13.4.1. Hospital pharmacies
    • 13.4.2. Retail pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By Country, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Treatment
    • 13.6.2. By Application
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country

14. Middle East & Africa Cat Allergy in Humans Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Treatment, 2017-2031
    • 14.2.1. Antihistamines
    • 14.2.2. Corticosteroid Nasal Sprays
    • 14.2.3. Decongestants
    • 14.2.4. Leukotriene Inhibitors
    • 14.2.5. Others
  • 14.3. Market Value Forecast By Application, 2017-2031
    • 14.3.1. Allergy Treatment
    • 14.3.2. Allergy Prevention
  • 14.4. Market Value Forecast By Distribution Channel, 2017-2031
    • 14.4.1. Hospital pharmacies
    • 14.4.2. Retail pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By Country, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Treatment
    • 14.6.2. By Application
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2020
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Strategic Overview
    • 15.3.2. Covis Pharma B.V
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
    • 15.3.3. HollisterStier Allergy.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Strategic Overview
    • 15.3.4. GlaxoSmithKline plc
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Strategic Overview
    • 15.3.5. Merck & Co. Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Strategic Overview
    • 15.3.6. Regeneron Pharmaceuticals, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Strategic Overview
    • 15.3.7. Saiba Animal Health AG
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
    • 15.3.8. Sanofi, Stallergenes Greer
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview